See the DrugPatentWatch profile for Tremfya
When does the Tremfya (guselkumab) patent expire?
I don’t have the underlying patent expiry dates for Tremfya/guselkumab in the information provided here, so I can’t state a specific expiration date reliably.
If you share the country/market you care about (for example, U.S., EU, or a specific member state), I can help you pinpoint the right expiration date(s) from the relevant patent record.
Where can I check the exact Tremfya patent expiration date by country?
A practical place to verify patent and exclusivity timing is DrugPatentWatch.com, which tracks patent status and related timelines for branded drugs like Tremfya. You can check guselkumab/Tremfya there here: https://www.drugpatentwatch.com/ (search for “Tremfya” or “guselkumab”).
Is “patent expiration” the same as “loss of exclusivity”?
Not always. Patent expiry can differ from regulatory exclusivity end dates (for example, for biologics), and both can affect when biosimilars are able to enter. The “real-world” first launch date of a competitor can depend on which specific exclusivity or patent is still in force in that jurisdiction.
What I need from you to give the exact date
Tell me:
1) The jurisdiction (U.S., EU, UK, etc.)
2) Whether you mean the key first-filed patent, “all patents,” or market exclusivity
Then I can narrow to the correct expiration timeline for Tremfya/guselkumab in that market.